Cargando…

Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2

SARS-CoV-2 Omicron BA.2.75 has diversified into multiple subvariants with additional spike mutations and several are expanding in prevalence, particularly CH.1.1 and BN.1. Here, we investigated the viral receptor affinities and neutralization evasion properties of major BA.2.75 subvariants actively...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qian, Li, Zhiteng, Guo, Yicheng, Mellis, Ian A., Iketani, Sho, Liu, Michael, Yu, Jian, Valdez, Riccardo, Lauring, Adam S., Sheng, Zizhang, Gordon, Aubree, Liu, Lihong, Ho, David D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654603/
https://www.ncbi.nlm.nih.gov/pubmed/38026207
http://dx.doi.org/10.1016/j.isci.2023.108254
_version_ 1785136660524040192
author Wang, Qian
Li, Zhiteng
Guo, Yicheng
Mellis, Ian A.
Iketani, Sho
Liu, Michael
Yu, Jian
Valdez, Riccardo
Lauring, Adam S.
Sheng, Zizhang
Gordon, Aubree
Liu, Lihong
Ho, David D.
author_facet Wang, Qian
Li, Zhiteng
Guo, Yicheng
Mellis, Ian A.
Iketani, Sho
Liu, Michael
Yu, Jian
Valdez, Riccardo
Lauring, Adam S.
Sheng, Zizhang
Gordon, Aubree
Liu, Lihong
Ho, David D.
author_sort Wang, Qian
collection PubMed
description SARS-CoV-2 Omicron BA.2.75 has diversified into multiple subvariants with additional spike mutations and several are expanding in prevalence, particularly CH.1.1 and BN.1. Here, we investigated the viral receptor affinities and neutralization evasion properties of major BA.2.75 subvariants actively circulating in different regions worldwide. We found two distinct evolutionary pathways and three newly identified mutations that shaped the virological features of these subvariants. One phenotypic group exhibited a discernible decrease in viral receptor affinities, but a noteworthy increase in resistance to antibody neutralization, as exemplified by CH.1.1, which is apparently as resistant as XBB.1.5. In contrast, a second group demonstrated a substantial increase in viral receptor affinity but only a moderate increase in antibody evasion, as exemplified by BN.1. We also observed that all prevalent SARS-CoV-2 variants in the circulation presently, except for BN.1, exhibit profound levels of antibody evasion, suggesting this is the dominant determinant of virus transmissibility today.
format Online
Article
Text
id pubmed-10654603
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106546032023-10-18 Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 Wang, Qian Li, Zhiteng Guo, Yicheng Mellis, Ian A. Iketani, Sho Liu, Michael Yu, Jian Valdez, Riccardo Lauring, Adam S. Sheng, Zizhang Gordon, Aubree Liu, Lihong Ho, David D. iScience Article SARS-CoV-2 Omicron BA.2.75 has diversified into multiple subvariants with additional spike mutations and several are expanding in prevalence, particularly CH.1.1 and BN.1. Here, we investigated the viral receptor affinities and neutralization evasion properties of major BA.2.75 subvariants actively circulating in different regions worldwide. We found two distinct evolutionary pathways and three newly identified mutations that shaped the virological features of these subvariants. One phenotypic group exhibited a discernible decrease in viral receptor affinities, but a noteworthy increase in resistance to antibody neutralization, as exemplified by CH.1.1, which is apparently as resistant as XBB.1.5. In contrast, a second group demonstrated a substantial increase in viral receptor affinity but only a moderate increase in antibody evasion, as exemplified by BN.1. We also observed that all prevalent SARS-CoV-2 variants in the circulation presently, except for BN.1, exhibit profound levels of antibody evasion, suggesting this is the dominant determinant of virus transmissibility today. Elsevier 2023-10-18 /pmc/articles/PMC10654603/ /pubmed/38026207 http://dx.doi.org/10.1016/j.isci.2023.108254 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Qian
Li, Zhiteng
Guo, Yicheng
Mellis, Ian A.
Iketani, Sho
Liu, Michael
Yu, Jian
Valdez, Riccardo
Lauring, Adam S.
Sheng, Zizhang
Gordon, Aubree
Liu, Lihong
Ho, David D.
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
title Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
title_full Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
title_fullStr Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
title_full_unstemmed Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
title_short Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
title_sort evolving antibody evasion and receptor affinity of the omicron ba.2.75 sublineage of sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654603/
https://www.ncbi.nlm.nih.gov/pubmed/38026207
http://dx.doi.org/10.1016/j.isci.2023.108254
work_keys_str_mv AT wangqian evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT lizhiteng evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT guoyicheng evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT mellisiana evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT iketanisho evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT liumichael evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT yujian evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT valdezriccardo evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT lauringadams evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT shengzizhang evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT gordonaubree evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT liulihong evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2
AT hodavidd evolvingantibodyevasionandreceptoraffinityoftheomicronba275sublineageofsarscov2